Global Amikacin (CAS 375125) Market is expected to grow at a CAGR of XX% during the forecast period. The major factors driving the growth of this market are increasing prevalence of bacterial infections, rising demand for amikacin eye drops and amikacin injection. However, high cost associated with amikacin eye drops and amikacin injection may hamper the growth of this market.
The global Amikacin (CAS 375125) market is segmented on the basis of type, application and region. On the basis of type, it is segmented into 98% purity type, 99% purity type and 99.8% purity type. On the basis of application it is segmented into amikacin eye drops and amikacin injection. On the basis of region it is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions.
Some Of The Growth Factors Of This Market:
- Amikacin is a potent antibiotic that is used to treat serious infections caused by bacteria such as pneumonia, meningitis, and sepsis.
- The drug has been approved for use in the United States since 1978 and is available in both intravenous and intramuscular forms.
- Amikacin has been shown to be effective against a wide range of Gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella enterica serovar Typhi (S. Typhi), Shigella dysenteriae type 1 (Sdys1), Vibrio cholerae serotype O1 (Vibrio cholerae O1) and Yersinia pestis (Yersinia pestis).
- The drug's effectiveness against Gram-positive bacteria such as Staphylococcus aureus or Streptococcus pyogenes is less clear but it may be useful for treating some infections caused by these organisms when other antibiotics are ineffective or contraindicated due to allergy or intolerance.
- Amikacin can cause side effects such as nausea, vomiting, diarrhea, headache and dizziness.
Industry Growth Insights published a new data on “Amikacin (CAS 37517-28-5) Market”. The research report is titled “Amikacin (CAS 37517-28-5) Market research by Types (98% Purity Type, 99% Purity Type, 99.8% Purity Type, Others), By Applications (Amikacin Eye Drops, Amikacin Injection, Others), By Players/Companies TargetMol, Pure Chemistry Scientific, Angene, Inter Bio Screen, MuseChem, Biosynth, Mucule, OChem, Clearsynth, 3B Scientific, Tuochukangyuan Pharm., Shenglide Biology, Bide Pharm., TNJ Chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Amikacin (CAS 37517-28-5) Market Research Report
By Type
98% Purity Type, 99% Purity Type, 99.8% Purity Type, Others
By Application
Amikacin Eye Drops, Amikacin Injection, Others
By Companies
TargetMol, Pure Chemistry Scientific, Angene, Inter Bio Screen, MuseChem, Biosynth, Mucule, OChem, Clearsynth, 3B Scientific, Tuochukangyuan Pharm., Shenglide Biology, Bide Pharm., TNJ Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Amikacin (CAS 37517-28-5) Market Report Segments:
The global Amikacin (CAS 37517-28-5) market is segmented on the basis of:
Types
98% Purity Type, 99% Purity Type, 99.8% Purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Amikacin Eye Drops, Amikacin Injection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- TargetMol
- Pure Chemistry Scientific
- Angene
- Inter Bio Screen
- MuseChem
- Biosynth
- Mucule
- OChem
- Clearsynth
- 3B Scientific
- Tuochukangyuan Pharm.
- Shenglide Biology
- Bide Pharm.
- TNJ Chemical
 Market Overview.svg)
Highlights of The Amikacin (CAS 37517-28-5) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 98% Purity Type
- 99% Purity Type
- 99.8% Purity Type
- Others
- By Application:
- Amikacin Eye Drops
- Amikacin Injection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amikacin (CAS 37517-28-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amikacin is a antibiotic. It is used to treat infections caused by bacteria.
Some of the major companies in the amikacin (cas 37517-28-5) market are TargetMol, Pure Chemistry Scientific, Angene, Inter Bio Screen, MuseChem, Biosynth, Mucule, OChem, Clearsynth, 3B Scientific, Tuochukangyuan Pharm., Shenglide Biology, Bide Pharm., TNJ Chemical.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Amikacin (CAS 37517-28-5) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Amikacin (CAS 37517-28-5) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Amikacin (CAS 37517-28-5) Market - Supply Chain
4.5. Global Amikacin (CAS 37517-28-5) Market Forecast
4.5.1. Amikacin (CAS 37517-28-5) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Amikacin (CAS 37517-28-5) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Amikacin (CAS 37517-28-5) Market Absolute $ Opportunity
5. Global Amikacin (CAS 37517-28-5) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Type
5.3.1. 98% Purity Type
5.3.2. 99% Purity Type
5.3.3. 99.8% Purity Type
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Amikacin (CAS 37517-28-5) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Application
6.3.1. Amikacin Eye Drops
6.3.2. Amikacin Injection
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Amikacin (CAS 37517-28-5) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Amikacin (CAS 37517-28-5) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Amikacin (CAS 37517-28-5) Demand Share Forecast, 2019-2026
9. North America Amikacin (CAS 37517-28-5) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Application
9.4.1. Amikacin Eye Drops
9.4.2. Amikacin Injection
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Type
9.7.1. 98% Purity Type
9.7.2. 99% Purity Type
9.7.3. 99.8% Purity Type
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Amikacin (CAS 37517-28-5) Demand Share Forecast, 2019-2026
10. Latin America Amikacin (CAS 37517-28-5) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Application
10.4.1. Amikacin Eye Drops
10.4.2. Amikacin Injection
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Type
10.7.1. 98% Purity Type
10.7.2. 99% Purity Type
10.7.3. 99.8% Purity Type
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Amikacin (CAS 37517-28-5) Demand Share Forecast, 2019-2026
11. Europe Amikacin (CAS 37517-28-5) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Application
11.4.1. Amikacin Eye Drops
11.4.2. Amikacin Injection
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Type
11.7.1. 98% Purity Type
11.7.2. 99% Purity Type
11.7.3. 99.8% Purity Type
11.7.4. Others
11.. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Amikacin (CAS 37517-28-5) Demand Share, 2019-2026
12. Asia Pacific Amikacin (CAS 37517-28-5) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Application
12.4.1. Amikacin Eye Drops
12.4.2. Amikacin Injection
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Type
12.7.1. 98% Purity Type
12.7.2. 99% Purity Type
12.7.3. 99.8% Purity Type
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Amikacin (CAS 37517-28-5) Demand Share, 2019-2026
13. Middle East & Africa Amikacin (CAS 37517-28-5) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Application
13.4.1. Amikacin Eye Drops
13.4.2. Amikacin Injection
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Amikacin (CAS 37517-28-5) Market Size and Volume Forecast by Type
13.7.1. 98% Purity Type
13.7.2. 99% Purity Type
13.7.3. 99.8% Purity Type
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Amikacin (CAS 37517-28-5) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Amikacin (CAS 37517-28-5) Market: Market Share Analysis
14.2. Amikacin (CAS 37517-28-5) Distributors and Customers
14.3. Amikacin (CAS 37517-28-5) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. TargetMol
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pure Chemistry Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Angene
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Inter Bio Screen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MuseChem
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biosynth
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mucule
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. OChem
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Clearsynth
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. 3B Scientific
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Tuochukangyuan Pharm.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shenglide Biology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Bide Pharm.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. TNJ Chemical
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
